Publications by authors named "Sheng Mei Mu"

Claim this Profile
E
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trial.
Lai Wei, Ji Dong Jia, Zhong Ping Duan, Fu Sheng Wang, Jun Qi Niu, Sheng Mei Mu

JGH Open· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection.
Lai Wei, Hiromitsu Kumada, Ponni V Perumalswami, Tawesak Tanwandee, Wendy Cheng, Sheng Mei Mu

J Gastroenterol Hepatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
Zhang-Rong Xu, Xing-Wu Ran, Yang Xian, Xiao-Dong Yan, Guo-Yue Yuan, Sheng-Mei Mu

J Antimicrob Chemother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of acetazolamide and anordiol on osmotic water permeability in AQP1-cRNA injected Xenopus oocyte.
Bing Ma, Yang Xiang, Sheng-Mei Mu, Tao Li, He-Ming Yu

Acta Pharmacol Sin· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Differential protein analysis in rat renal proximal tubule epithelial cells in response to acetazolamide and its relation with the inhibition of AQP1].
Sheng-mei Mu, Xun-he Ji, Bing Ma, He-ming Yu, Xue-jun Li

Yao Xue Xue Bao· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis